Title : Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis.

Pub. Date : 1997 Sep-Oct

PMID : 9385476






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 IFN-beta reduces the number of new T2-weighted lesions, as well as the number and volume of gadolinium-enhanced lesions. Gadolinium interferon beta 1 Homo sapiens